G. Hardavella (Aghia Paraskevi, Athens, Greece), T. Mairinger (Berlin, Germany)
Transcriptional expression of human telomerase reverse transcriptase (hTERT) and indoleamine 2,3-dioxygenase (IDO) in non-small cell lung cancer
T. Kerenidi, M. Zamanakou, S. Tsochas, V. Karanikas, A. E. Germenis, K. I. Gourgoulianis (Greece)
|  |
Specific plasmids encoding shRNA molecules directed against growth factor receptors in cell proliferation inhibition and induction phenotype changes relevant to enhancement of anti-tumor immunity. Model of human non-small (NSCLC) and small (SCLC) cell lung cancer lines
P. Kopinski, J. Kowalewski, A. Goc, M. Jankowski, M. Dancewicz, E. Polgesek (Bydgoszcz, Torun, Poland)
| |
Involvement of Fas/FasL system in gemcitabine-induced lung cancer cell killing
L. Siena, E. Pace, M. Ferraro, C. Di Sano, M. Melis, M. Profita, M. Gjomarkaj (Palermo, Italy)
| |
Acute effects of cisplatin on mucociliary function: In vitro measurements
M. Petrova, A. Bergner, F. Tian, R. M. Huber, F. Gamarra (Munich, Germany)
|  |
Nadroparin inhibits A549 human adenocarcinoma cell proliferation through down-regulation of cyclin B1 and G2/M phase cell-cycle arrest
Y. Carmazzi, M. Iorio, F. Raggi, S. Cianchetti, T. Neri, C. Cordazzo, R. Vanacore, F. Bogazzi, P. Paggiaro, A. Celi (Pisa, Italy)
| |
MicroRNA-101 inhibits lung cancer growth and invasion through regulation of EZH2
M. J. Na, S. J. Kwon, E. Choi, J. K. Kang, S. K. Kim, S. Y. Lee, S. Y. Park, J. U. Lee, Y. J. Kim, J. W. Son (Daejeon, Republic Of Korea)
| |
D2-40 as a diagnostic marker for pulmonary squamous cell carcinoma
K. H. Min, Y. C. Lee, S. J. Park, M. J. Chung, S. R. Kim, M. H. Lee, C. R. Chung, H. J. Han, W. S. Lee (Jeonju, Republic Of Korea)
| |
Autophagy induces cytoprotection in cisplatin-treated lung cancer cells
S. H. Yang, H. Y. Jang, H. J. Jo, K. K. Lee, S. R. Moon, S. A Park, S. Y. Lee (Iksan, Republic Of Korea)
| |
ROS production in PMN is higher during inflammation in NSCLC than in COPD
N. Vaguliene, M. Zemaitis, A. Babusyte, S. Miliauskas, R. Sakalauskas (Kaunas, Lithuania)
| |
D104N poluymorphism in endostatin, an angiogenesis inhibitor, in lung cancer susceptibility
L. Zambon, H. Honma, G. Lourenço, I. Saad, R. Mussi, C. Lima (Brazil)
| |
The role of regulator and effector T lymphocytes in chronic obstructive pulmonary disease and lung cancer
G. Galffy, D. Bartusek, A. Cseh, A. Nagy, Z. Szarvas, R. Horvath, Z. Komlósi, B. Vasarhelyi, G. Losonczy (Budapest, Hungary)
| |
Endotoxin induces proliferation of NSCLC cells by a COX-2 dependent manner – Role of CD14, TLRs and EGFR signaling
K. Hattar, R. Savai, G. A. Banat, R. T. Schermuly, L. Fink, W. Seeeger, F. Grimminegr, U. Sibelius, U. Grandel (Giessen, Germany)
| |
Dehydrocostuslactone-induced apoptosis through oxidative and endoplasmic reticulum stress signaling in human non-small cell lung cancer cells
J. Y. Hung, Y. L. Hsu, W. C. Ni, Y. M. Tsai, C. J. Yang, M. S. Huang, P. L. Kuo (Taiwan)
| |
Lung cancer-derived IL-8 increased osteoclastogenesis via phospholipase D signaling pathway
Y. L. Hsu, J. Y. Hung, Y. C. Ko, C. H. Hung, M. S. Huang, P. L. Kuo (Taiwan)
| |
Enhanced expression of nicotinic alpha-1 acetylcholine receptor in lung cancer
K. Tanaka, W. Shuo, M. Takeshita, M. Izumi, K. Takayama, Y. Nakanishi (Fukuoka, Japan)
| |
Nrf2-Dependent overexpression of sulfiredoxin and peroxiredoxin III in human lung cancer
S. C. Hwang, Y. J. Jung, W. Y. Jung, K. S. Lee, J. H. Park, Y. S. Kim, H. L. Lee, K. J. Park (Suwon, Republic Of Korea)
| |
Interactions between neutrophils and NSCLC cells in vitro – effects on neutrophil inflammatory mediator generation and tumor cell proliferation
U. Grandel, K. Franz, M. Ludwig, W. Seeger, F. Grimminger, U. Sibelius, K. Hattar (Giessen, Germany)
| |
Long-term proteasome inhibition promotes chemical lung carcinogenesis
S. P. Karabela, C. A. Kairi, I. Psallidas, F. McMahon, L. A. Gleaves, W. Han, S. Vassiliou, C. Roussos, I. Kalomenidis, F. E. Yull, S. G. Zakynthinos, T. S. Blackwell, G. T. Stathopoulos (Patra, Greece; Nashville, United States Of America)
| |
Roles of volume-sensitive Cl- channel in cisplatin resistance of human lung adenocarcinoma cells
X. Min, H. Li, J. Liu, J. Wang (Beijing, China)
| |